Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Transl Stroke Res. 2015 Nov 17;7(2):120–131. doi: 10.1007/s12975-015-0433-7

Figure 2.

Figure 2

Non-involvement of HO1/Wnt pathway in EGb 761 neuroprotection. A) Protein expression levels showed that EGb 761 pretreatment did not upregulate HO1 expression after pMCAO as a protective mechanism. Intact female mice were used as positive control. C) Wnt expression also showed a similar pattern as that of HO1. (B and D) Corresponding graph shows the densitometric analysis normalized to actin. Data are expressed as mean ± SEM; *p<0.05, vs. vehicle-treated control or Intact (n=5), Veh/OVX (n=5) and EGb 761/OVX (n=5)